Asian race and origin have no clinically meaningful effects on polatuzumab vedotin pharmacokinetics in patients with relapsed/refractory B-cell non-Hodgkin lymphoma

被引：0
作者：
Rong Shi
Tong Lu
Grace Ku
Hao Ding
Tomohisa Saito
Leonid Gibiansky
Priya Agarwal
Xiaobin Li
Jin Yan Jin
Sandhya Girish
Dale Miles
Chunze Li
Dan Lu
机构：
[1] Genentech Inc.,
[2] Chugai Pharmaceutical Co.,undefined
[3] Ltd.,undefined
[4] QuantPharm LLC,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2020年 / 86卷
关键词：
Ethnic sensitivity assessment; NHL; Non-hodgkin lymphoma; PK; Polatuzumab vedotin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：347 / 359
页数：12
相关论文
共 50 条
[41]   Application of a Two-Analyte Integrated Population Pharmacokinetic Model to Evaluate the Impact of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Polatuzumab Vedotin in Patients with Non-Hodgkin Lymphoma [J].
Dan Lu ;
Tong Lu ;
Rong Shi ;
Leonid Gibiansky ;
Priya Agarwal ;
Colby S. Shemesh ;
Randall C. Dere ;
Uzor Ogbu ;
Jamie Hirata ;
Pascal Chanu ;
Sandhya Girish ;
Jin Yan Jin ;
Chunze Li ;
Dale Miles .
Pharmaceutical Research, 2020, 37
[42]   Application of a Two-Analyte Integrated Population Pharmacokinetic Model to Evaluate the Impact of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Polatuzumab Vedotin in Patients with Non-Hodgkin Lymphoma [J].
Lu, Dan ;
Lu, Tong ;
Shi, Rong ;
Gibiansky, Leonid ;
Agarwal, Priya ;
Shemesh, Colby S. ;
Dere, Randall C. ;
Ogbu, Uzor ;
Hirata, Jamie ;
Chanu, Pascal ;
Girish, Sandhya ;
Jin, Jin Yan ;
Li, Chunze ;
Miles, Dale .
PHARMACEUTICAL RESEARCH, 2020, 37 (12)
[43]   Cystatin C as a potential marker for relapse in patients with non-Hodgkin B-cell lymphoma [J].
Mulaomerovic, Adaleta ;
Halilbasic, Alma ;
Cickusic, Elmir ;
Zavasnik-Bergant, Tina ;
Begic, Lejla ;
Kos, Janko .
CANCER LETTERS, 2007, 248 (02) :192-197
[44]   Phase Ib Open-Label Study of Loncastuximab Tesirine in Combination With Other Anticancer Agents in Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (LOTIS-7) [J].
Hess, Brian ;
Solh, Melhem ;
Gandhi, Mitul ;
Wang, Ying ;
Qin, Yajuan ;
Zinzani, Pier Luigi ;
Collins, Graham .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 :S419-S420
[45]   Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study [J].
Abrisqueta, Pau ;
Gonzalez-Barca, Eva ;
Panizo, Carlos ;
Perez, Jose Maria Arguinano ;
Miall, Fiona ;
Bastos-Oreiro, Mariana ;
Triguero, Ana ;
Banerjee, Lalita ;
Mcmillan, Andrew ;
Seymour, Erlene ;
Hirata, Jamie ;
de Guzman, Jayson ;
Sharma, Sunil ;
Jin, Hyun Yong ;
Musick, Lisa ;
Diefenbach, Catherine .
LANCET HAEMATOLOGY, 2024, 11 (02) :e136-e146
[46]   Outcomes of polatuzumab vedotin-containing regimens in real-world setting of relapsed and or refractory diffuse large B-cell lymphoma patients: a matched-control analysis from the Thai Lymphoma Study Group (TLSG) [J].
Rattanathammethee, Thanawat ;
Norasetthada, Lalita ;
Bunworasate, Udomsak ;
Wudhikarn, Kitsada ;
Julamanee, Jakrawadee ;
Noiperm, Panarat ;
Lanamtieng, Theerin ;
Phiphitaporn, Pisa ;
Navinpipat, Manassamon ;
Kanya, Piyapong ;
Jit-ueakul, Dusit ;
Wongkhantee, Somchai ;
Suwannathen, Thanongsak ;
Chaloemwong, Juthatip ;
Wong, Peerapon ;
Makruasi, Nisa ;
Khuhapinant, Archrob ;
Prayongratana, Kannadit ;
Niparuck, Pimjai ;
Kanitsap, Nonglak ;
Suwanban, Tawatchai ;
Intragumtornchai, Tanin .
ANNALS OF HEMATOLOGY, 2023, 102 (07) :1887-1895
[47]   Safety of Bendamustine for the Treatment of Patients with B-Cell Non-Hodgkin Lymphoma, a Retrospective Cohort Study [J].
Cristaldo, Nancy ;
Warley, Fernando ;
Fantl, Dorotea ;
Basquiera, Ana ;
Otero, Victoria .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 :S292-S292
[48]   Bendamustine for the Treatment of Chronic Lymphocytic Leukemia and Rituximab-Refractory, Indolent B-Cell Non-Hodgkin Lymphoma [J].
Dennie, Trevor W. ;
Kolesar, Jill M. .
CLINICAL THERAPEUTICS, 2009, 31 :2290-2311
[49]   Randomized phase II study of a bendamustine monotherapy schedule for relapsed or refractory low-grade B-cell non-Hodgkin lymphoma or mantle cell lymphoma (RABBIT-14) [J].
Itoh, Kuniaki ;
Igarashi, Tadahiko ;
Irisawa, Hiroyuki ;
Aotsuka, Nobuyuki ;
Masuda, Shinichi ;
Utsu, Yoshikazu ;
Tsujimura, Hideki ;
Tsukasaki, Kunihiro ;
Wakita, Hisashi .
LEUKEMIA & LYMPHOMA, 2018, 59 (07) :1606-1613
[50]   A phase I study evaluating ibritumomab tiuxetan (Zevalin®) in combination with bortezomib (Velcade®) in relapsed/refractory mantle cell and low grade B-cell non-Hodgkin lymphoma [J].
Beaven, Anne W. ;
Shea, Thomas C. ;
Moore, Dominic T. ;
Feldman, Tatyana ;
Ivanova, Anastasia ;
Ferraro, Madlyn ;
Ford, Peggy ;
Smith, Judith ;
Goy, Andre .
LEUKEMIA & LYMPHOMA, 2012, 53 (02) :254-258
12345